Investors SEC Filing Details Sign up for email alerts to receive company and investor updates SEC Filing Details Investor Relations Investor Relations News Releases Presentations & Events Common Stock Information Stock Quote & Chart Analyst Coverage SEC Filings Corporate Governance Overview Board of Directors Committee Composition Management Team Annual Reports Document Details Form 424B5 Filing Date 03/30/22 Document Date 03/30/22 Form Description Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 Filing Group Registration Statements Company Cyclacel Pharmaceuticals, Inc. Issuer Cyclacel Pharmaceuticals, Inc. Filing Formats View HTML Download PDF Download DOC Toolkit Email AlertsRSS FeedsPrint Page
Document Details Form 424B5 Filing Date 03/30/22 Document Date 03/30/22 Form Description Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 Filing Group Registration Statements Company Cyclacel Pharmaceuticals, Inc. Issuer Cyclacel Pharmaceuticals, Inc. Filing Formats View HTML Download PDF Download DOC